Clinical Trials Browser

Cell- and Tissue-Based Therapy × Tumor-Agnostic × Clear all

NCT02193503 2023-09-28

MVX-ONCO-1 in Patients With Solid Tumor

Phase 1 Active not recruiting

Neoplasms

NCT00149006 2007-03-14

Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors

Phase 2 Unknown

Neoplasm Metastasis, Neoplasms